NSE / BSEHealthcare
β‚Ή277.20-1.25-0.45%
P/E42.6Mkt Capβ‚Ή4.06 K CrEV/EBITDA32.0

Artemis Medicare Services Limited

P/E42.6Mkt Capβ‚Ή4.06 K CrEV/EBITDA32.0
Company Profile

Artemis Medicare Services Limited engages in the management and operation of multi-specialty hospitals in India and internationally. The company provides medical and surgical intervention, and inpatient and outpatient services. It also offers billing and insurance, childcare, emotional and support program, full body checkup, international patient, medical interpreter and record, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation program services, as well as home care services. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 28 Jul 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Sign up free to view AI insights

Get Started

Rule-based from financial data. Not advice.

Price Historyβ–² 16.37% over 1Y
Monthly Returns

Historically, Jul has averaged the highest return (+16.5%); Feb the lowest (-12.1%).

Average from:
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026-8.7%Negative MonthJan 2026: -8.73%-3.7%Negative MonthFeb 2026: -3.74%-13.8%Negative MonthMar 2026: -13.80%+19.1%Positive MonthApr 2026: +19.15%+12.3%Positive MonthMay 2026: +12.29%-3.5%Negative MonthJun 2026: -3.51%+4.6%*Positive MonthJul 2026: +4.62%β€”β€”β€”β€”β€”
2025-0.0%Neutral MonthJan 2025: -0.02%-26.0%Negative MonthFeb 2025: -25.96%+17.7%Positive MonthMar 2025: +17.67%-7.8%Negative MonthApr 2025: -7.77%+10.4%Positive MonthMay 2025: +10.36%-9.0%Negative MonthJun 2025: -9.05%-6.1%Negative MonthJul 2025: -6.09%-8.4%Negative MonthAug 2025: -8.39%+6.8%Positive MonthSep 2025: +6.81%+6.0%Positive MonthOct 2025: +6.01%+15.3%Positive MonthNov 2025: +15.26%-5.1%Negative MonthDec 2025: -5.10%
2024+3.1%Positive MonthJan 2024: +3.06%-8.3%Negative MonthFeb 2024: -8.25%-0.2%Neutral MonthMar 2024: -0.18%+7.4%Positive MonthApr 2024: +7.45%-4.5%Negative MonthMay 2024: -4.47%+1.9%Neutral MonthJun 2024: +1.89%+48.5%Positive MonthJul 2024: +48.54%+8.3%Positive MonthAug 2024: +8.32%-0.7%Neutral MonthSep 2024: -0.66%-1.9%Neutral MonthOct 2024: -1.90%+18.4%Positive MonthNov 2024: +18.37%-4.3%Negative MonthDec 2024: -4.31%
2023-7.9%Negative MonthJan 2023: -7.94%-7.7%Negative MonthFeb 2023: -7.70%+5.2%Positive MonthMar 2023: +5.19%+16.4%Positive MonthApr 2023: +16.44%+8.4%Positive MonthMay 2023: +8.42%+45.7%Positive MonthJun 2023: +45.74%+2.7%Positive MonthJul 2023: +2.66%-2.4%Negative MonthAug 2023: -2.41%+26.2%Positive MonthSep 2023: +26.19%-2.9%Negative MonthOct 2023: -2.87%+11.2%Positive MonthNov 2023: +11.22%+5.2%Positive MonthDec 2023: +5.20%
2022+10.5%Positive MonthJan 2022: +10.53%-14.9%Negative MonthFeb 2022: -14.94%+16.8%Positive MonthMar 2022: +16.79%-2.7%Negative MonthApr 2022: -2.72%-6.5%Negative MonthMay 2022: -6.49%-0.4%Neutral MonthJun 2022: -0.36%+30.6%Positive MonthJul 2022: +30.65%+15.5%Positive MonthAug 2022: +15.46%-2.4%Negative MonthSep 2022: -2.39%+16.3%Positive MonthOct 2022: +16.33%+11.3%Positive MonthNov 2022: +11.30%-4.0%Negative MonthDec 2022: -3.97%
2021β€”β€”β€”β€”β€”+18.8%Positive MonthJun 2021: +18.84%+18.8%Positive MonthJul 2021: +18.82%-9.6%Negative MonthAug 2021: -9.64%+3.8%Positive MonthSep 2021: +3.85%-5.3%Negative MonthOct 2021: -5.29%-1.0%Neutral MonthNov 2021: -1.03%+24.2%Positive MonthDec 2021: +24.22%
AvgΒ±SD-0.6%Β±7.2%-12.1%Β±7.8%+5.1%Β±11.7%+6.5%Β±10.5%+4.0%Β±7.9%+8.9%Β±18.6%+16.5%Β±18.6%+0.7%Β±9.7%+6.8%Β±10.2%+2.5%Β±7.9%+11.0%Β±6.6%+3.2%Β±11.2%
* Current month β€” value will change until month-end.

Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β€” the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.

Seasonal Tendency

This aggregates every month by calendar position β€” all Januaries together, all Februaries together, and so on β€” to show whether a given month has leaned positive or negative historically. β€˜Simple’ counts each month as +1 or βˆ’1. β€˜Weighted’ gives larger moves more influence: +2 above +10%, βˆ’2 below βˆ’10%. With only 6 years of history for this asset, each month’s score reflects a small number of observations β€” read it as a historical tendency, not a reliable seasonal pattern.

Historical Trend

This tracks a running tally across the asset’s full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.

Year-to-Date ROI
Average from:
SD Γ—
Latest: 1.023x (2026)

Year-to-date return is calculated by dividing each day’s closing price by the price on January 1st of that year (or the asset’s first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β€” at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in β€œAverage from”, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή913.00 Crβ–² 8.0%
EBITDA Growthβ€”
Net Profitβ‚Ή83.00 Crβ–² 69.4%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–Ό 450.0%
Revenue CAGR 5Y8.5%
EBITDA CAGR 5Y15.4%
Net Profit CAGR 5Y19.6%
NP Growth 1Y69.4%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή913.00 Crβ€”β‚Ή83.00 Crβ€”β€”9.9%8.0%69.4%
Mar 2024β‚Ή845.00 Crβ€”β‚Ή49.00 Crβ€”β€”10.8%18.3%22.5%
Mar 2023β‚Ή714.00 Crβ€”β‚Ή40.00 Crβ€”β€”9.9%31.0%21.2%
Mar 2022β‚Ή545.00 Crβ€”β‚Ή33.00 Crβ€”β€”9.1%35.6%371.4%
Mar 2021β‚Ή402.00 Crβ€”β‚Ή7.00 Crβ€”β€”2.2%-28.6%-65.0%
Mar 2020β‚Ή563.00 Crβ€”β‚Ή20.00 Crβ€”β€”6.4%2.9%-4.8%
Mar 2019β‚Ή547.00 Crβ€”β‚Ή21.00 Crβ€”β€”7.5%8.7%-22.2%
Mar 2018β‚Ή503.00 Crβ€”β‚Ή27.00 Crβ€”β€”11.7%9.6%0.0%
Mar 2017β‚Ή459.00 Crβ€”β‚Ή27.00 Crβ€”β€”13.2%14.2%22.7%
Mar 2016β‚Ή402.00 Crβ€”β‚Ή22.00 Crβ€”β€”12.0%9.2%15.8%

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Consolidated Figures in USD Millions.

Unnamed: 0Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue / Net Sales261368402459503547563402545714845913981
Total Expenses234325359406442480501367477620717763818
EBIT / Operating Profit27434353606662356894128150163
OPM %11%12%11%11%12%12%11%9%12%13%15%16%17%
Other Income135432473773336
Finance Costs13129991113121119303029
Depreciation & Amortisation9121215182022212129384344
Profit Before Tax72127323537329395368109126
Tax %0%12%21%16%24%44%36%20%16%25%28%24%-
Net Profit / PAT719222727212073340498395
EPS (β‚Ή)0.320.881.031.291.270.981.540.542.462.963.626.076.90
Dividend Payout %0%0%0%0%0%0%0%0%0%15%12%7%-

Peer Comparison

Healthcare sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
Artemis Medicare Services Limitedthis co.β‚Ή4.06 K Crβ‚Ή913.00 Cr42.604.0132.038.0%
Sun Pharmaceutical Industries Ltd.β‚Ή4.15 L Crβ‚Ή23.00 K Cr88.7017.4372.3013.5%
Divi's Laboratories Ltd.β‚Ή1.71 L Crβ‚Ή9.20 K Cr67.9011.1367.2120.0%
Torrent Pharmaceuticals Ltd.β‚Ή1.33 L Crβ‚Ή9.68 K Cr62.5015.7645.6413.5%
Cipla Ltd.β‚Ή1.17 L Crβ‚Ή19.05 K Cr22.503.5119.3314.9%
Apollo Hospitals Enterprises Ltd.β‚Ή1.05 L Crβ‚Ή8.20 K Cr75.0011.2854.4412.8%
Max Healthcare Institute Limitedβ‚Ή1.00 L Crβ‚Ή2.66 K Cr144.0011.7696.8413.8%
Industry Averageβ€”β‚Ή3.29 K Cr98.638.1165.5020.2%

Learn while you research

Hand-picked academy chapters to deepen your understanding of Artemis Medicare Services Limited and the metrics that matter.

Browse the full Equiscale Academy